Stemedyne™-MSC, mesenchymal stem cells for ischemic stroke

Stemedyne™-MSC are bone marrow-derived mesenchymal stem cells. Cells of the most viable colonies are cultured in a low oxygen environment, enabling larger product yields, at the highest levels of quality and consistency. Stemedyne™-MSC are then intravenously injected to treat ischemic stroke.